Digital Agenda for Europe
A Europe 2020 Initiative

Workshop on "High Performance Computing (HPC) in Health Research"

Article
As High Performance Computing (HPC) is a crucial technology for addressing complex issues in health research, DG Research and Innovation and DG CONNECT are organising a workshop on 1-2 October 2014, that aims to identify current and future health research requirements for HPC and to explore mechanisms of addressing them through co-operation of relevant stakeholders.
Share this
Date: 
From 01/10/2014 to 02/10/2014
Venue: 
Brussels, Belgium

The workshop will bring together high level experts from health-related industries, health researchers, and representatives of HPC industries and supercomputing centres.

  

Final Programme

High Performance Computing in Health Research

Brussels, 1 - 2 October 2014

Venue: CDMA, rue du Champ de Mars 21, 1050 Brussels

 

High Performance Computing (HPC) is a crucial technology for addressing complex issues in health research. This workshop aims to identify current and future health research requirements for HPC and will explore mechanisms of addressing them through co-operation of relevant stakeholders. The workshop will bring together high level experts from health-related industries, health researchers, and representatives of HPC industries and supercomputing centres. Presentations and panel debates will explore key challenges facing health research, the role of HPC and future actions. Research and innovation opportunities like Centre of Excellence in HPC for health research will also be explored.

 Day 1

13.30-14.00     Registration

14:00 – 14:30  Welcome address: HPC Strategy and Health Research

[Thierry van Der Pyl, Director "Excellence in Science" DG CONNECT, European Commission]

[Ruxandra Draghia-Akli, Director "Health", DG Research & Innovation, European Commission]

[Paul Timmers, Director "Sustainable & Secure Society" DG CONNECT, European Commission]

 14:30 – 14:45  HPC Centre of Excellence: An opportunity

                [Aniyan Varghese, DG Connect, European Commission]

14:45 – 15:05  Can HPC help answering medically relevant questions?

                [Jesper Tegner, Karolinska University Hospital]

 15:05 – 15:25 Europe needs HPC in Drug Discovery

               [Andrea R. Beccari, Drug Discovery Platform Manager, Dompé]

 15:25 – 15:45  HPC and in silico clinical trials: AVICENNA roadmap

            http://www.avicenna-isct.org  

            [Marco Viceconti - Avicenna ]

 15:45 – 16:00  The role of PRACE for Health Research

                             http://www.prace-ri.eu

            [Sanzio Bassini- PRACE Chair]

 16:00 – 16:15  Coffee break

 16:15 – 16:30  The needs for HPC in life sciences and health research

[Steven Newhouse, European Bioinformatics Institute, Member of BioMedBridges]

16:30 – 17:30  Panel: Current needs for HPC in health research

Panel moderator:      Alf Game (Chairman of the Board of ELIXIR)

Participants:

 17:45               Cocktail

 Day 2

09:00 – 09:15  Making the most of imaging data: the example of brain imaging

[Nikolaos Koutsouleris, Ludwig-Maximilians-Universität Munich,                           Coordinator of PRONIA]

09:15 – 10:15  Panel: Can existing infrastructures answer identified HPC needs for health research?

Panel Moderator:        Wouter Spek (EuroBioForum)

Participants:

 10:15 – 10:30 Keynote speech on future challenges

[Magda Chlebus (Director of Science Policy, European Federation of    Pharmaceutical Industries and Associations)]

 10:30 – 10:45  Coffee Break

 10:45 – 11:45  Panel: Future activities and implementation

Panel co-moderators: Gitte Moos Knudsen (Chairman of the Neurobiology Research Unit, Director of the Centre for Integrated Molecular Brain Imaging) 

                                        Ian Cree (Yvonne Carter Professor of Pathology, Warwick Medical School)

Participants:

  • Bernadette Andrietti (European Technology Platform for High Performance Computing (ETP4HPC) www.etp4hpc.eu)
  • Peter Longreen (Elixir: European Bioinformatics infrastructure http://www.elixir-europe.org)
  • Yann le Cam (Chief Executive Officer of the European Organisation for Rare Diseases, Eurordis)
  • Jan Bogaerts (Vice Director of the European Organisation for Research and Treatment of Cancer)
  • Gunaretnam Rajagopal, (VP, Global Head of Computational Sciences, Discovery Sciences at Janssen)
  • Yi-Ke Guo (Professor of Computing Science, Imperial College London; Innovative Medicines Initiative project eTRIKS)

 11:45 – 12:30  Synthesis and next steps

 [EC representative and Rapporteur]

 12:30               Sandwich lunch

Short CVs and Pictures

final synthesis slides

list of participants

Report